Excess Mortality in Aspirin and Dipyrone (Metamizole) Co‐Medicated in Patients With Cardiovascular Disease: A Nationwide Study

Excess Mortality in Aspirin and Dipyrone (Metamizole) Co‐Medicated in Patients With Cardiovascular Disease: A Nationwide Study

Background Pain is a major issue in our aging society. Dipyrone (metamizole) is one of the most frequently used analgesics. Additionally, it has been shown to impair pharmacodynamic response to aspirin as measured by platelet function tests. However, it is not known how this laboratory effect transl...

Full description

Saved in:
Bibliographic Details
Main Authors: Amin Polzin, Lisa Dannenberg, Carolin Helten, Martin Pöhl, Daniel Metzen, Philipp Mourikis, Christof Dücker, Ursula Marschall, Helmut L’Hoest, Beata Hennig, Saif Zako, Kajetan Trojovsky, Tobias Petzold, Christian Jung, Bodo Levkau, Tobias Zeus, Karsten Schrör, Thomas Hohlfeld, Malte Kelm
Format: article
Language:EN
Published: Wiley 2021
Subjects:
aggregation
aspirin
co‐medication
dipyrone
platelet activation
platelet inhibition
Diseases of the circulatory (Cardiovascular) system
RC666-701
Online Access:https://doaj.org/article/46863831286544e9afcf8e597f1baae2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/46863831286544e9afcf8e597f1baae2

Similar Items